- Home
- GNLX vs SENS Comparison
GNLX vs SENS Comparison
Compare GNLX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNLX | SENS |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 308.5M |
| IPO Year | 2022 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GNLX | SENS |
|---|---|---|
| Price | $2.41 | $6.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $19.80 | ★ $22.70 |
| AVG Volume (30 Days) | 129.7K | ★ 522.3K |
| Earning Date | 03-19-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.47 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,000.00 | ★ $16,389,000.00 |
| Revenue This Year | N/A | $70.20 |
| Revenue Next Year | N/A | $59.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $1.99 | $0.41 |
| 52 Week High | $8.54 | $8.75 |
Technical Indicators
Market Signals| Indicator | GNLX | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 36.16 | 48.71 |
| Support Level | $2.35 | $6.62 |
| Resistance Level | $2.86 | $8.55 |
| Average True Range (ATR) | 0.14 | 0.47 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 16.53 | 76.66 |
Price Performance
Historical ComparisonAbout GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.